Overall, we were able to demonstrate the presence of survivin in 74% of IBC and 73% of DCIS, with DCIS showing stronger expression levels than invasive cancer; indicating that survivin expression may be an early event in the malignant process. Here, BIRC5 is linked to ductal breast carcinoma in situ.